Evaluation of Horizontal Bone Gain in the Lower Posterior Partially Edentulous Patient Comparing the Stabilization of Membranes With and Without Tacs
Radiographic And Clinical Evaluation of Horizontal Bone Gain in the Lower Posterior Partially Edentulous Patients Comparing the Stabilization of The Resorbable Collagen Membrane With and Without Tacs
1 other identifier
interventional
22
0 countries
N/A
Brief Summary
To address the gap of knowledge in comparing between the bone augmentation outcomes with or without tacks for membrane stabilization
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2024
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 5, 2024
CompletedFirst Posted
Study publicly available on registry
February 13, 2024
CompletedStudy Start
First participant enrolled
February 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2024
CompletedFebruary 13, 2024
February 1, 2024
1 month
February 5, 2024
February 5, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Horizontal bone gain assessed radiographically (mm)
Using CBCT
Baseline , 4 month
Secondary Outcomes (6)
Horizontal bone gain assessed clinically (mm)
Baseline , 4 month
Amount of Pain
7 days
Amount of Pain
7 days
Patient satisfaction
4 month
Surgical Time
During Surgery
- +1 more secondary outcomes
Study Arms (2)
Patient showing horizontal defect and treated with GBR stabilized with Tacs
ACTIVE COMPARATORFixation
Patient showing horizontal defect and treated with GBR stabilized with no Tacs
EXPERIMENTALNo Fixation
Interventions
After local anesthesia, a crestal incision will be performed followed by full-thickness mucoperiosteal flap elevation Flap advancement will be attained through periosteal scoring of the buccal; The resorbable collagen membrane (Bio Gide, Geistlich AG) will be trimmed to the defect size. Xenograft (Bio-Oss) together with scrapped autogenous bone will be mixed and placed at the surgical site. The membrane will positioned over the graft and tucked into the lingual flap. Patient allocation concealment will be broken and the patients will be randomly assigned into two groups Patients receiving horizontal bone augmentation with resorbable collagen membrane stabilized with no tacks. The first layer will be closed with horizontal mattress sutures placed 4 mm from the incision line, and single interrupted sutures are used to close the edges of the flap. Vertical incisions are closed using single interrupted sutures and mattress suture should remain in place for at least 2 to 3 weeks
Eligibility Criteria
You may qualify if:
- Patients with at least 1 missing tooth in the posterior mandibular area Patients with an age above 18 years Systemically healthy patients
- Healed alveolar ridge for implant placement with:
- Deficient buccolingual dimension ( ≤5mm)
- Sufficient vertical height (≥ 10 mm)
- Sufficient mesio-distal width (≥ 6.5 mm) Inter-arch space ≥ 7 mm to allow space for implant-supported crown Presence of neighboring and opposing dentition Soft tissue phenotype with keratinized tissue width (KTW) (≥2 mm) and gingival thickness (≥2 mm) Good oral hygiene Cooperative patients who accepted the trial follow up period and sign the informed consen
You may not qualify if:
- Systemic diseases or medications that might affect bone metabolism, increase surgical risk or complicate post-operative healing Untreated periodontal diseases History of radiation therapy to the head and neck Heavy smokers (≥ 10 cigarettes per day) Pregnant or lactating females Alcoholism or drug abuse Psychiatric problems Patients with signs of acute infection related to the area of interest
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
- Misr International Universitycollaborator
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Hani ElNahass, PhD
Cairo University
- STUDY CHAIR
Omnia Tawfik, PhD
Cairo University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor of Periodontology
Study Record Dates
First Submitted
February 5, 2024
First Posted
February 13, 2024
Study Start
February 15, 2024
Primary Completion
March 30, 2024
Study Completion
June 30, 2024
Last Updated
February 13, 2024
Record last verified: 2024-02